EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Stefano Margaritora
Alfredo Cesario
Pierluigi Granone
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margaritora, S.
Right arrow Articles by Granone, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Margaritora, S.
Right arrow Articles by Granone, P.
Related Collections
Right arrow Pleura

Eur J Cardiothorac Surg 2007;32:397. doi:10.1016/j.ejcts.2007.05.007
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved


Letters to the Editor

Single versus multiple access video-assisted thoracic surgery in the treatment of malignant pleural effusion

Stefano Margaritoraa, Alfredo Cesarioa,b,*, Maria Letizia Vitaa, Pierluigi Granonea

a Division of General Thoracic Surgery, Catholic University, Rome, Italy
b Pulmonary Rehabilitation, IRCCS San Raffaele, Rome, Italy

Received 6 March 2007; accepted 11 May 2007.

* Corresponding author. Address: Division of General Thoracic Surgery, Catholic University, Largo A. Gemelli 8, 00168 Rome, Italy. Tel.: +39 03358366161; fax: +39 063051162. (Email: alfcesario{at}rm.unicatt.it).

Key Words: Pleural effusion • Videothoracoscopy • Talc poudrage

Talc pleurodesis for malignant pleural effusion (MPE) is a procedure which, undoubtedly, is useful in the approach to advanced stage cancer patients whose quality of life is severely impaired by this clinical occurrence. In this setting, we really appreciate the report from Stefani and co-workers [1] that, even within the limits of a prospective non-randomized trial, gives a clear and evidence-based rationale to support talc poudrage for MPE per se and suggests some valuable criteria to support the decision-making process towards the indication for a videothoracoscopic procedure (thoracoscopic talc poudrage—TP) or a bedside one (talc slurry—TS).

We now had time to evaluate retrospectively our experience with 317 patients with MPE who, in the period from January 1995 to December 2006, underwent TP. In the same period, 76 patients underwent bedside TS, due to very poor clinical conditions. The comparison of these two groups in terms of efficacy (successful pleurodesis within 90 days from procedure) largely confirms the authors’ conclusion that TP is better than TS (87.5% vs 72.3%, p < 0.01). Unlike the figures reported in [1], the incidence of post-procedural pain was different, but not significantly, in the two groups.

Herein we would like to report our results when a single access thoracoscopic procedure is compared with a multiple accesses procedure (two or more). Of the 317 patients, in fact, 187 underwent a single access procedure (group A) in which a 5 mm camera was introduced in the same port (12 mm) along with instruments for suction, pleurolysis-biopsy and poudrage (pneumatically atomized talc – 6 g – through a soft silicone tube); a single chest drain, 28 Fr, was inserted through the same hole. The remaining 130 cases underwent a standard, multiple accesses procedure (group B). Morbidity and mortality (30-day procedure related, nil in both groups) did not differ between the two groups. Analgesic drug administration (elastomeric pump for continuous infusion of 20 mg morphine plus 150 mg ketorolac at 2 ml/h/48 h) was discontinued after 48 h in 81% of the patients in group A and in 61% in group B (p = 0.0001). No statistical differences in terms of procedure efficacy (endpoint: MPE recurrence) were found between the two groups.

Our results strongly support the value of TP in the treatment of MPE as reported in [1]. We would really appreciate the authors’ reflection and reaction in considering and discussing a single approach for TP.

References

  1. Stefani A, Natali P, Casali C, Morandi U. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur J Cardiothorac Surg 2006;30(6):827-832.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Stefani, P. Natali, C. Casali, and U. Morandi
Reply to Margaritora et al.
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 397 - 398.
[Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Stefano Margaritora
Alfredo Cesario
Pierluigi Granone
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Margaritora, S.
Right arrow Articles by Granone, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Margaritora, S.
Right arrow Articles by Granone, P.
Related Collections
Right arrow Pleura


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS